Cochlear Stock Fundamentals
| COH Stock | 290.51 2.93 1.00% |
Cochlear fundamentals help investors to digest information that contributes to Cochlear's financial success or failures. It also enables traders to predict the movement of Cochlear Stock. The fundamental analysis module provides a way to measure Cochlear's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cochlear stock.
At this time, Cochlear's Total Operating Expenses is comparatively stable compared to the past year. Income Before Tax is likely to gain to about 509 M in 2024, whereas Tax Provision is likely to drop slightly above 81 M in 2024. Cochlear | Select Account or Indicator |
Cochlear Company Operating Margin Analysis
Cochlear's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Cochlear Operating Margin | 0.22 % |
Most of Cochlear's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cochlear is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Cochlear has an Operating Margin of 0.2205%. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The operating margin for all Australia stocks is notably lower than that of the firm.
Cochlear Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cochlear's current stock value. Our valuation model uses many indicators to compare Cochlear value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cochlear competition to find correlations between indicators driving Cochlear's intrinsic value. More Info.Cochlear is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.60 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Cochlear is roughly 1.66 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cochlear's earnings, one of the primary drivers of an investment's value.Cochlear Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cochlear's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cochlear could also be used in its relative valuation, which is a method of valuing Cochlear by comparing valuation metrics of similar companies.Cochlear is currently under evaluation in operating margin category among its peers.
Cochlear ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cochlear's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cochlear's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Cochlear Fundamentals
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 18.74 B | ||||
| Shares Outstanding | 65.43 M | ||||
| Shares Owned By Insiders | 0.51 % | ||||
| Shares Owned By Institutions | 48.55 % | ||||
| Price To Book | 10.33 X | ||||
| Price To Sales | 8.53 X | ||||
| Revenue | 2.26 B | ||||
| Gross Profit | 1.45 B | ||||
| EBITDA | 578.9 M | ||||
| Net Income | 356.8 M | ||||
| Cash And Equivalents | 555.5 M | ||||
| Total Debt | 243.7 M | ||||
| Book Value Per Share | 28.10 X | ||||
| Cash Flow From Operations | 388.8 M | ||||
| Earnings Per Share | 5.43 X | ||||
| Target Price | 294.95 | ||||
| Number Of Employees | 5 K | ||||
| Beta | 0.46 | ||||
| Market Capitalization | 19.06 B | ||||
| Total Asset | 2.75 B | ||||
| Retained Earnings | 667.9 M | ||||
| Working Capital | 820.6 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 2.75 B | ||||
| Last Dividend Paid | 4.1 |
About Cochlear Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cochlear's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cochlear using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cochlear based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 66.7 M | 70 M | |
| Total Revenue | 2.3 B | 2.4 B | |
| Cost Of Revenue | 562.1 M | 590.2 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cochlear Stock Analysis
When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.